Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

MAbs for treatment of melanoma

April 5, 1996

BMS reports mutant BR96 antibodies

April 5, 1996

Yakult Honsha claims camptothecin derivatives

April 5, 1996

DuPont Merck research into protease inhibitors

April 5, 1996

New protease inhibitors from BMS

April 5, 1996

BMS discloses novel cephalosporins

April 5, 1996

Lilly's tachykinin antagonists for chronic pain

April 5, 1996

Tsumura Juntendo research into aldose reductase inhibitors

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...